Biomedical stakeholders caution against limiting U.S.-China collaboration

A group of nearly 150 U.S. academics and biomedical research and drug development stakeholders warned that actions which create a climate of fear or limit international collaboration between U.S. and Chinese scientists could jeopardize U.S. leadership in biomedical science.

In a letter to the Nature Research Bioengineering Community, they state that an atmosphere of intimidation could limit the ability to attract scientists of Chinese origin and cause others to leave the U.S., citing summary dismissals of academic scientists and government actions that limit international collaboration...